Surasak Komonchan* and Yodkhwan Wattanasen

Neurological institute of Thailand, Bangkok, Thailand

*Corresponding Author: Surasak Komonchan; Neurological institute of Thailand, Bangkok, Thailand.

Received: February 01, 2024; Published: February 28, 2024

Abstract

Stroke is currently the main cause of morbidity and mortality in neurological diseases. Treatment in the acute stage is important and the turning point to reduce the severity of the stroke or even return the patient to a normal state. Since 2015, mechanical thrombectomy has become the standard treatment, Like the thrombolysis guidelines that have been updated to treat acute ischemic stroke patients in even more conditions, mechanical thrombectomy would likely follow the same pathway from real clinical cases around the world.

References

Desai SM., et al. “Thrombectomy 6-24 hours after stroke in trial ineligible patients”. Journal of NeuroInterventional Surgery 10 (2018): 1033-1037.

Ospel JM and Goyal M. “A review of endovascular treatment for medium vessel occlusion stroke”. Journal of NeuroInterventional Surgery 13 (2021): 623-630.

Garg R and Biller J. “Neuroimaging Predictors of Clinical Outcome in Acute Basilar Artery Occlusion”. Frontiers in Neurology 8 (2017): 293.

Citation

Citation: Surasak Komonchan and Yodkhwan Wattanasen. “Extension of the Indication for Mechanical Thrombectomy”. Acta Scientific Neurology 7.3 (2024): 32-34.

Copyright

Copyright: © 2024 Surasak Komonchan and Yodkhwan Wattanasen. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.